Pathology

The Department of Pathology at Peking University International Hospital is one of the earliest established and most important platform departments of the institution. Over nearly a decade of continuous development since 2014, it has grown into a modern pathology department of considerable scale, providing crucial support for the diagnosis and treatment of various clinical diseases within the hospital.

The department currently has 16 staff members. The physician team includes 3 professors or chief physicians, 2 associate chief physicians, 3 attending physicians, and 2 resident physicians. The technical team consists of 1 associate chief technician, 3 senior technicians, and 2 technicians; the vast majority hold master's degrees or higher.

The current director, Professor Li Ting, is a renowned pathologist in China. He served for nearly 20 years as the director of the Department of Pathology at Peking University First Hospital and is currently the leader of the Pathology Group of the Clinical Expert Committee for Standardized Residency and Specialist Training at Peking University. Professor Li specializes in the pathological diagnosis of common and complex multisystem diseases, with particular expertise in hematolymphoid system, breast diseases, skin, and thoracic tumors. He has undertaken multiple research projects, including five funded by the National Natural Science Foundation, and has published over 100 academic articles, more than 30 of which are indexed by SCI.

Associate Director Ren Yubo is highly accomplished in cytology, especially in the field of thyroid fine-needle aspiration cytology. Several other experts from the department hold positions in the Beijing Pathology Branch and other professional societies. Young physicians are actively developing and are principal investigators in hospital key and rising star research projects.

Currently, the department integrates both routine and cutting-edge technologies for pathological diagnosis and assessment, providing definitive disease diagnoses, prognostic evaluation, standardized pathological assessment of various surgical specimens, scientifically guided companion diagnostics for targeted therapies, and molecular genetic analysis of neoplastic diseases. The department has established a comprehensive diagnostic platform that combines pathological morphology, immunohistochemical analysis, and molecular techniques.